Grace Laboratory

Chronic pain afflicts 100 million Americans, and therapies that target only neurons are minimally effective. The Grace Lab in MD Anderson's Department of Symptom Research is tackling this problem through research to understand the neuroimmune mechanisms that underlie chronic pain and its control. With an overarching interest in pharmacology and drug discovery, we leverage mouse models, genetic and pharmacological manipulations, behavioral assessments, primary cell culture, microscopy, and cell and molecular biology approaches. Our research is supported by the National Institutes of Health, Department of Defense, and Kleberg Foundation.